PMID- 10448933 OWN - NLM STAT- MEDLINE DCOM- 19990908 LR - 20190624 IS - 0014-2999 (Print) IS - 0014-2999 (Linking) VI - 377 IP - 1 DP - 1999 Jul 14 TI - A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. PG - 101-15 AB - We report the cloning, functional expression and cell-specific localization of the rat homologue of the prostaglandin D2 receptor (DP). In situ hybridization, utilizing multiple digoxigenin-labelled riboprobes and their complementary sense controls, was performed to determine the detailed distribution of DP receptor mRNA in the central nervous system and the gastrointestinal tract. Within the brain, the leptomeninges and choroid plexus expressed DP receptor mRNA. Transcripts detected in the spinal cord were localized to the sensory and motor neurons of the dorsal and ventral horns, respectively, suggesting a role for the DP receptor in the modulation of central nervous system processes, including pain transmission. Within the gastrointestinal tract (stomach, duodenum, ileum and colon) signals were highly localized to the mucous-secreting goblet cells and the columnar epithelium. These findings suggest a novel biological role for prostaglandin D2-mediated activity at the DP receptor, namely mucous secretion. In addition, radioligand binding assays (saturation analyses and equilibrium competition assays) and functional assays (measuring cAMP accumulation) were performed to characterize the recombinant rat DP receptor expressed in human embryonic kidney (HEK) 293(EBNA) cells. A single site of binding (K(D) = 14 nM, Bmax = 115 fmol/mg protein) was measured for prostaglandin D2-specific binding to the rat DP receptor. Prostaglandin D2 proved to be a potent agonist at the rat DP receptor (EC50 = 5 nM). The rank order of efficacy for DP receptor specific agonists [prostaglandin D2 = prostaglandin J2 = BW 245C (5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropylhydantoin)) > L-644,698 ((4-(3-(3-(3-hydroxyoctyl)-4-oxo-2-thiazolidinyl) propyl) benzoic acid) (racemate)] reflected the affinity with which the ligands bound to the receptor. FAU - Wright, D H AU - Wright DH AD - Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada. FAU - Nantel, F AU - Nantel F FAU - Metters, K M AU - Metters KM FAU - Ford-Hutchinson, A W AU - Ford-Hutchinson AW LA - eng SI - GENBANK/AF120101 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Epitopes) RN - 0 (Oligopeptides) RN - 0 (Peptides) RN - 0 (RNA Probes) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Immunologic) RN - 0 (Receptors, Prostaglandin) RN - 0 (Recombinant Fusion Proteins) RN - 98849-88-8 (FLAG peptide) RN - E0399OZS9N (Cyclic AMP) RN - RXY07S6CZ2 (Prostaglandin D2) RN - XZF106QU24 (prostaglandin D2 receptor) SB - IM MH - Amino Acid Sequence MH - Animals MH - Binding, Competitive MH - Cell Line MH - Cell Membrane/metabolism MH - Cloning, Molecular MH - Cyclic AMP/biosynthesis MH - Epitopes MH - Gene Expression MH - Humans MH - In Situ Hybridization MH - Molecular Sequence Data MH - Oligopeptides MH - Peptides/genetics MH - Prostaglandin D2/*physiology MH - RNA Probes MH - RNA, Messenger/genetics/metabolism MH - Radioligand Assay MH - Rats MH - *Receptors, Immunologic MH - Receptors, Prostaglandin/genetics/*metabolism MH - Recombinant Fusion Proteins/genetics/metabolism MH - Sequence Homology, Amino Acid MH - Tissue Distribution EDAT- 1999/08/17 00:00 MHDA- 1999/08/17 00:01 CRDT- 1999/08/17 00:00 PHST- 1999/08/17 00:00 [pubmed] PHST- 1999/08/17 00:01 [medline] PHST- 1999/08/17 00:00 [entrez] AID - S0014-2999(99)00358-1 [pii] AID - 10.1016/s0014-2999(99)00358-1 [doi] PST - ppublish SO - Eur J Pharmacol. 1999 Jul 14;377(1):101-15. doi: 10.1016/s0014-2999(99)00358-1.